Open AccessLevosimendan in lung transplant recipients on VA‑ECMO
Author(s) -
С. В. Журавель,
В. Э. Александрова,
И. И. Уткина,
Kuznetsova Na,
Е. А. Тарабрин
Publication year - 2020
Publication title -
vestnik transplantologii i iskusstvennyh organov
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 5
eISSN - 2412-6160
pISSN - 1995-1191
DOI - 10.15825/1995-1191-2020-1-118-122
Subject(s) - levosimendan , extracorporeal membrane oxygenation , medicine , lung transplantation , lung , cardiology , heart transplantation , heart failure , transplantation , intensive care medicine , anesthesia
Chronic heart failure is one of the most dreadful complications in the early postoperative period following lung transplantation. At the same time, the effect of using levosimendan in the early post-lung transplant period is currently insignificant and remains debatable. This paper presents a clinical case where levosimendan was successfully used in a patient with right ventricular heart failure during lung transplantation undergoing central venoarterial extracorporeal membrane oxygenation (VA-ECMO).